"Reduce the import tax rates, and actively expand import, should not be expedient to ease domestic inflationary pressures from the economic logic of sense, the fundamental purpose of import, China electronic thermometer manufacturer we do not have to import something or someone better this point in the future Pharmaceutical import and export trade to maintain a clear understanding of the import should be more emphasis on the quality of imports. "
China's foreign trade winds are shifting. Department of Commerce recently announced the import and export trade New Deal: Comparison of 2011 China stressed that "China medical thermometer ;adhere to both exports and imports", 2012, in order to achieve "reduction surplus, and promote balance" of economic goals, but also large-scale imports have been given a new mission,digital blood pressure monitor Department of Commerce proposed to "strengthen and improve the import work, and actively expand import, promote trade balance." Can be predicted, then the import and export will further open the door, whether this will lead to more "wolf" or a balance of trade war quietly? Has always been sensitive to the policy judgments of the new pharmaceutical industry began to change.
In fact, digital thermometer manufacturer import and export of Chinese Medicine in 2011 is already showing a trade balance trend. According to latest customs data show that: the pattern of changes in the global pharmaceutical market and the development of strong domestic demand,digital thermometer China's pharmaceutical and other internal and external factors together, China's pharmaceutical import and export trade to achieve more substantial growth. 1 October 2011, total import and export of pharmaceutical $ 59,349,000,000, an increase of 39.66%. Among this, exports 36.297 billion U.S. dollars, an increase of 35.87%; imported $ 23.052 billion, an increase of 46.08%. Overall, the global pharmaceutical market trends for the smooth development of foreign trade of China's pharmaceutical market provides a favorable environment, but still more uncertainty, the global economic recovery slowed down and increased risk of medical trade growth rate down, China's pharmaceutical traditional advantages of facing new challenges facing export development approach to change, challenges and opportunities coexist. However, it should be noted that domestic demand remains strong momentum of growth, innovation and high-growth pharmaceutical imports, import and export volume accounting for surplus accounted for 22.32%, which fell 3.4 percentage points.
Foreign brands recapture gates
With the "security exports, expansion of imports," the relevant supporting policies were introduced, an flood of imports is bound to affect the policy-sensitive pharmaceutical industry. The reporter learned that many local enterprises to worry about, because the blockade of foreign high-tech imports put drugs gate than the greatest impact, Yi Xie and other products like the supply of imported drugs will not take the opportunity to seize the Chinese increasingly heavy volume of the pharmaceutical market? Especially drugs to further reduce tariffs, more conducive to the cost of imported drugs decrease the price of imported drugs would certainly fall.
"In this case, relative to the domestic price of drugs, imported drugs cost will increase, thus further formation of the domestic impact of drugs. More need to think, if imported drugs diverted to the domestic market pharmaceutical companies, which are unable to explore the use of international pharmaceuticals market, then the local pharmaceutical companies have the danger of shrinking, of course, the danger is invisible, need national enterprises foresight, early response. "Jiangsu Kang edge medicine chairman Xiao Wei had not help to issue such a sigh. However, the subject, he said: "coins have two sides, so that local businesses will be forced to increase the drug independent research and innovation efforts and sense of urgency, in turn, stimulate domestic enterprises' independent innovation."
The deeper level is concerned, imported drugs pharmaceutical industry more dash of fear, because since joining the WTO, the import of medicines, medical equipment imports, not only to China to bring high-quality, more importantly, it also brings High drug prices, high costs of diagnosis, and the introduction of marketing concept, resulting in daikin sales, rebates and other negative effects, the impact of the national medicine and healthy development.
Chinese Academy of Sciences Institute of Economics, Professor Zhu Hengpeng that doctors are now imported drugs, prescription drugs open the precious enthusiasm is still high, interest will continue to drive demand for the release of imported drugs. The doctor's income is often linked with the hospital's income, thus contributing to the hospital with joint ventures, foreign production of drugs.